30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Aratana Therapeutics Inc (PETX)

Track

Stock chart
Ticker: PETX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
AYRES JOHN C
SEE REMARKS
1 sale — total 13,094 USD
Planned sale 30 Jan 2019
Value US$2,250,307.59 | Price 239.50 | Shares 61,606
Planned sale 17 Dec 2018
Value US$84,815.25 | Price 466.25 | Shares 81,801
Planned sale 7 Nov 2018
Value US$134,190.60 | Price 6.95 | Shares 19,308
Planned sale 2 Nov 2018
Value US$4,809.40 | Price 6.95 | Shares 692
Planned sale 30 Oct 2018
Value US$67,453.52 | Price 5.86 | Shares 11,513
Planned sale 21 Sep 2018
Value US$454,305.00 | Price 6.06 | Shares 75,000
Planned sale 14 Aug 2018
Value US$8,816.80 | Price 5.15 | Shares 1,712
Planned sale 13 Aug 2018
Value US$44,599.00 | Price 5.15 | Shares 8,660
Planned sale 10 Aug 2018
Value US$10,063.10 | Price 5.15 | Shares 1,954
Planned sale 8 Aug 2018
Value US$13,771.10 | Price 5.15 | Shares 2,674
Planned sale 30 Jul 2018
Value US$49,842.08 | Price 4.33 | Shares 11,513
Planned sale 25 Jun 2018
Value US$45,644.00 | Price 4.56 | Shares 10,000
Planned sale 30 Jan 2018
Value US$92,301.19 | Price 4.77 | Shares 19,367
Planned sale 11 Jan 2018
Value US$158,040.00 | Price 5.27 | Shares 30,000
Sale 1 Dec 2017
Value US$2,296,609.20 | Price 5.40 | Shares 425,298
Sale 1 Dec 2017
Value US$10,336.00 | Price 5.44 | Shares 1,900
Sale 1 Dec 2017
Value US$272,500.00 | Price 5.45 | Shares 50,000
Sale 1 Dec 2017
Value US$547.00 | Price 5.47 | Shares 100
Sale 1 Dec 2017
Value US$28,207.20 | Price 5.52 | Shares 5,110
Sale 1 Dec 2017
Value US$44,350.60 | Price 5.53 | Shares 8,020
Sale 1 Dec 2017
Value US$406,800.00 | Price 5.65 | Shares 72,000
Sale 30 Nov 2017
Value US$295,000.00 | Price 5.90 | Shares 50,000
Sale 30 Nov 2017
Value US$297,500.00 | Price 5.95 | Shares 50,000
Sale 30 Nov 2017
Value US$595,000.00 | Price 5.95 | Shares 100,000
Sale 30 Nov 2017
Value US$68,487.84 | Price 5.97 | Shares 11,472
Sale 30 Nov 2017
Value US$603.00 | Price 6.03 | Shares 100
Sale 29 Nov 2017
Value US$11,894.00 | Price 6.26 | Shares 1,900
Sale 29 Nov 2017
Value US$1,884.00 | Price 6.28 | Shares 300
Sale 29 Nov 2017
Value US$48,895.00 | Price 6.35 | Shares 7,700
Sale 29 Nov 2017
Value US$325,000.00 | Price 6.50 | Shares 50,000
Sale 29 Nov 2017
Value US$37,669.05 | Price 6.55 | Shares 5,751
Sale 29 Nov 2017
Value US$329,109.00 | Price 6.60 | Shares 49,865
Sale 29 Nov 2017
Value US$6,660.00 | Price 6.66 | Shares 1,000
Planned sale 10 Nov 2017
Value US$350,000.00 | Price 7.00 | Shares 50,000
Planned sale 2 Oct 2017
Value US$312,115.00 | Price 6.24 | Shares 50,000
Planned sale 25 Sep 2017
Value US$61,127.00 | Price 6.11 | Shares 10,000
Planned sale 15 Sep 2017
Value US$62,500.00 | Price 6.25 | Shares 10,000
Planned sale 17 Apr 2017
Value US$277,150.00 | Price 5.54 | Shares 50,000
Planned sale 27 Jan 2017
Value US$385,875.00 | Price 7.72 | Shares 50,000
Planned sale 15 Dec 2016
Value US$381,380.00 | Price 7.63 | Shares 50,000
Planned sale 3 Oct 2016
Value US$100,006.00 | Price 10.00 | Shares 10,000
Planned sale 9 Sep 2016
Value US$277,599.00 | Price 9.25 | Shares 30,000
Planned sale 9 Aug 2016
Value US$462,500.00 | Price 9.25 | Shares 50,000
Planned sale 28 Jun 2016
Value US$187,500.00 | Price 6.25 | Shares 30,000
Planned sale 17 Jun 2016
Value US$158,020.00 | Price 6.32 | Shares 25,000
Planned sale 16 Jun 2016
Value US$468,292.50 | Price 6.24 | Shares 75,000
Planned sale 10 Jun 2016
Value US$100,861.50 | Price 6.72 | Shares 15,000
Planned sale 1 Feb 2016
Value US$9,436.02 | Price 3.36 | Shares 2,806
Planned sale 27 Apr 2015
Value US$52,073.34 | Price 15.78 | Shares 3,300
Planned sale 27 Apr 2015
Value US$172,911.96 | Price 14.78 | Shares 11,700
Planned sale 2 Jan 2015
Value US$446,647.50 | Price 17.87 | Shares 25,000
Sale 10 Mar 2014
Value US$12,012,000.00 | Price 20.02 | Shares 600,000
Sale 7 Mar 2014
Value US$250,153.05 | Price 19.95 | Shares 12,539
Sale 7 Mar 2014
Value US$538,534.08 | Price 20.16 | Shares 26,713
Sale 3 Feb 2014
Value US$856,900.00 | Price 19.00 | Shares 45,100
Sale 3 Feb 2014
Value US$8,643,100.00 | Price 19.00 | Shares 454,900
Sale 3 Feb 2014
Value US$15,675,000.00 | Price 19.00 | Shares 825,000
Sale 3 Feb 2014
Value US$15,675,000.00 | Price 19.00 | Shares 825,000
Buy 2 Jul 2013
Value US$49,998.00 | Price 6.00 | Shares 8,333
Buy 2 Jul 2013
Value US$12,000.00 | Price 6.00 | Shares 2,000
Buy 2 Jul 2013
Value US$3,000,000.00 | Price 6.00 | Shares 500,000
Buy 2 Jul 2013
Value US$3,000,000.00 | Price 6.00 | Shares 500,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-02-01 2019-01-30 PlS Planned sale
AYRES JOHN C

SEE REMARKS

Officer
61,606 +20.3%
239.50
US$2,250,308 		61,606 +20.3% 239.50 US$2,250,308
2018-12-17 2018-12-17 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
81,801 -2.3%
466.25
US$84,815 		81,801 -2.3% 466.25 US$84,815
2018-11-09 2018-11-07 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
49,501 -30.4%
263.83
US$143,362 		49,501 -30.4% 263.83 US$143,362
2018-11-06 2018-11-02 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
692 -0.4%
6.95
US$4,809 		692 -0.4% 6.95 US$4,809
2018-10-31 2018-10-30 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
11,513 -2.0%
5.86
US$67,454 		11,513 -2.0% 5.86 US$67,454
2018-09-21 2018-09-21 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
75,000 -11.6%
6.06
US$454,305 		75,000 -11.6% 6.06 US$454,305
2018-08-14 2018-08-14 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
1,712 -1.1%
5.15
US$8,817 		1,712 -1.1% 5.15 US$8,817
2018-08-14 2018-08-13 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
8,660 -5.2%
5.15
US$44,599 		8,660 -5.2% 5.15 US$44,599
2018-08-10 2018-08-10 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
1,954 -1.2%
5.15
US$10,063 		1,954 -1.2% 5.15 US$10,063
2018-08-10 2018-08-08 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
2,674 -1.6%
5.15
US$13,771 		2,674 -1.6% 5.15 US$13,771
2018-07-30 2018-07-30 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
11,513 -1.7%
4.33
US$49,842 		11,513 -1.7% 4.33 US$49,842
2018-06-27 2018-06-25 PlS Planned sale Standridge Brent

Chief Operating Officer

Officer
10,000 -9.1%
4.56
US$45,644 		10,000 -9.1% 4.56 US$45,644
2018-02-01 2018-01-30 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
19,367 -2.8%
4.77
US$92,301 		19,367 -2.8% 4.77 US$92,301
2018-01-12 2018-01-11 PlS Planned sale TOOMAN CRAIG A

CHIEF FINANCIAL OFFICER

Officer
30,000 -28.6%
5.27
US$158,040 		30,000 -28.6% 5.27 US$158,040
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
425,298 -9.0%
5.40
US$2,296,609 		425,298 -9.0% 5.40 US$2,296,609
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,900 -0.0%
5.44
US$10,336 		1,900 -0.0% 5.44 US$10,336
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -1.0%
5.45
US$272,500 		50,000 -1.0% 5.45 US$272,500
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100 -0.0%
5.47
US$547 		100 -0.0% 5.47 US$547
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
5,110 -0.1%
5.52
US$28,207 		5,110 -0.1% 5.52 US$28,207
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
8,020 -0.2%
5.53
US$44,351 		8,020 -0.2% 5.53 US$44,351
2017-12-01 2017-12-01 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
72,000 -1.5%
5.65
US$406,800 		72,000 -1.5% 5.65 US$406,800
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -1.0%
5.90
US$295,000 		50,000 -1.0% 5.90 US$295,000
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -1.0%
5.95
US$297,500 		50,000 -1.0% 5.95 US$297,500
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100,000 -2.0%
5.95
US$595,000 		100,000 -2.0% 5.95 US$595,000
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
11,472 -0.2%
5.97
US$68,488 		11,472 -0.2% 5.97 US$68,488
2017-12-01 2017-11-30 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100 -0.0%
6.03
US$603 		100 -0.0% 6.03 US$603
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,900 -0.0%
6.26
US$11,894 		1,900 -0.0% 6.26 US$11,894
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
300 -0.0%
6.28
US$1,884 		300 -0.0% 6.28 US$1,884
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
7,700 -0.2%
6.35
US$48,895 		7,700 -0.2% 6.35 US$48,895
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -1.0%
6.50
US$325,000 		50,000 -1.0% 6.50 US$325,000
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
5,751 -0.1%
6.55
US$37,669 		5,751 -0.1% 6.55 US$37,669
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
49,865 -1.0%
6.60
US$329,109 		49,865 -1.0% 6.60 US$329,109
2017-12-01 2017-11-29 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
1,000 -0.0%
6.66
US$6,660 		1,000 -0.0% 6.66 US$6,660
2017-11-13 2017-11-10 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -8.6%
7.00
US$350,000 		50,000 -8.6% 7.00 US$350,000
2017-10-04 2017-10-02 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.9%
6.24
US$312,115 		50,000 -7.9% 6.24 US$312,115
2017-09-27 2017-09-25 PlS Planned sale Standridge Brent

Chief Operating Officer
10,000 -12.5%
6.11
US$61,127 		10,000 -12.5% 6.11 US$61,127
2017-09-19 2017-09-15 PlS Planned sale HEINEN ERNST

Chief Development Officer
10,000 -7.1%
6.25
US$62,500 		10,000 -7.1% 6.25 US$62,500
2017-04-18 2017-04-17 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.9%
5.54
US$277,150 		50,000 -7.9% 5.54 US$277,150
2017-01-31 2017-01-27 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.3%
7.72
US$385,875 		50,000 -7.3% 7.72 US$385,875
2016-12-16 2016-12-15 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -8.4%
7.63
US$381,380 		50,000 -8.4% 7.63 US$381,380
2016-10-04 2016-10-03 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
10,000 -8.0%
10.00
US$100,006 		10,000 -8.0% 10.00 US$100,006
2016-09-12 2016-09-09 PlS Planned sale TOOMAN CRAIG A

CHIEF FINANCIAL OFFICER

Officer
30,000 -29.3%
9.25
US$277,599 		30,000 -29.3% 9.25 US$277,599
2016-08-10 2016-08-09 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
50,000 -7.2%
9.25
US$462,500 		50,000 -7.2% 9.25 US$462,500
2016-06-28 2016-06-28 PlS Planned sale STEPHANUS JULIA A

CHIEF COMMERCIAL OFFICER

Officer
30,000 -19.0%
6.25
US$187,500 		30,000 -19.0% 6.25 US$187,500
2016-06-17 2016-06-17 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
25,000 -3.5%
6.32
US$158,020 		25,000 -3.5% 6.32 US$158,020
2016-06-17 2016-06-16 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
75,000 -9.5%
6.24
US$468,292 		75,000 -9.5% 6.24 US$468,292
2016-06-13 2016-06-10 PlS Planned sale HEINEN ERNST

Chief Development Officer

Officer
15,000 -10.7%
6.72
US$100,862 		15,000 -10.7% 6.72 US$100,862
2016-02-02 2016-02-01 PlS Planned sale TOOMAN CRAIG A

CHIEF FINANCIAL OFFICER

Officer
2,806 -2.7%
3.36
US$9,436 		2,806 -2.7% 3.36 US$9,436
2015-04-28 2015-04-27 PlS Planned sale Rhodes Linda

CHIEF SCIENTIFIC OFFICER

Officer
3,300 -0.8%
15.78
US$52,073 		3,300 -0.8% 15.78 US$52,073
2015-04-28 2015-04-27 PlS Planned sale Rhodes Linda

CHIEF SCIENTIFIC OFFICER

Officer
11,700 -2.7%
14.78
US$172,912 		11,700 -2.7% 14.78 US$172,912
2015-01-06 2015-01-02 PlS Planned sale St Peter Steven

PRESIDENT AND CEO

Executive Director
25,000 -3.5%
17.87
US$446,648 		25,000 -3.5% 17.87 US$446,648
2014-03-12 2014-03-10 S Sale MPM BIOVENTURES V, L.P. Large shareholder
600,000 -17.9%
20.02
US$12,012,000 		600,000 -17.9% 20.02 US$12,012,000
2014-03-11 2014-03-07 S Sale Foley Todd Large shareholder
12,539 -100.0%
19.95
US$250,153 		12,539 -100.0% 19.95 US$250,153
2014-03-11 2014-03-07 S Sale GADICKE ANSBERT Large shareholder
26,713 -100.0%
20.16
US$538,534 		26,713 -100.0% 20.16 US$538,534
2014-02-05 2014-02-03 S Sale MEEUSEN RONALD L Non-Executive Director
45,100 -37.4%
19.00
US$856,900 		45,100 -37.4% 19.00 US$856,900
2014-02-05 2014-02-03 S Sale MEEUSEN RONALD L Non-Executive Director
454,900 -37.4%
19.00
US$8,643,100 		454,900 -37.4% 19.00 US$8,643,100
2014-02-05 2014-02-03 S Sale Avalon Ventures IX, L.P. Large shareholder
825,000 -19.8%
19.00
US$15,675,000 		825,000 -19.8% 19.00 US$15,675,000
2014-02-05 2014-02-03 S Sale Lichter Jay Non-Executive Director Large shareholder
825,000 -19.8%
19.00
US$15,675,000 		825,000 -19.8% 19.00 US$15,675,000
2013-07-03 2013-07-02 B Purchase St Peter Steven

PRESIDENT AND CEO

Executive Director
8,333 +1.6%
6.00
US$49,998 		8,333 +1.6% 6.00 US$49,998
2013-07-03 2013-07-02 B Purchase STEPHANUS JULIA A

CHIEF COMMERCIAL OFFICER

Officer
2,000 +1.5%
6.00
US$12,000 		2,000 +1.5% 6.00 US$12,000
2013-07-02 2013-07-02 B Purchase Vander Vort John Non-Executive Director Large shareholder
500,000 +13.0%
6.00
US$3,000,000 		500,000 +13.0% 6.00 US$3,000,000
2013-07-02 2013-07-02 B Purchase MPM BIOVENTURES V, L.P. Large shareholder
500,000 +13.0%
6.00
US$3,000,000 		500,000 +13.0% 6.00 US$3,000,000
Explore more

More insider trading research around Aratana Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America